Background-Diabetes mellitus and obesity, which confer an increased risk of sudden cardiac death, are associated with cardiomyocyte lipid accumulation and altered cardiac electric properties, manifested by prolongation of the QRS duration and QT interval. It is difficult to distinguish the contribution of cardiomyocyte lipid accumulation from the contribution of global metabolic defects to the increased incidence of sudden death and electric abnormalities. Methods and Results-In order to study the effects of metabolic abnormalities on arrhythmias without the complex systemic effects of diabetes mellitus and obesity, we studied transgenic mice with cardiac-specific overexpression of peroxisome proliferator-activated receptor ␥ 1 (PPAR␥1) via the cardiac ␣-myosin heavy-chain promoter. The PPAR␥ transgenic mice develop abnormal accumulation of intracellular lipids and die as young adults before any significant reduction in systolic function. Using implantable ECG telemeters, we found that these mice have prolongation of the QRS and QT intervals and spontaneous ventricular arrhythmias, including polymorphic ventricular tachycardia and ventricular fibrillation. Isolated cardiomyocytes demonstrated prolonged action potential duration caused by reduced expression and function of the potassium channels responsible for repolarization. Short-term exposure to pioglitazone, a PPAR␥ agonist, had no effect on mortality or rhythm in WT mice but further exacerbated the arrhythmic phenotype and increased the mortality in the PPAR␥ transgenic mice. Conclusions-Our findings support an important link between PPAR␥ activation, cardiomyocyte lipid accumulation, ion channel remodeling, and increased cardiac mortality. (Circulation. 2011;124:2812-2821.)
D iseases that affect cardiac energy metabolism and increase cardiomyocyte lipid stores, such as diabetes and obesity, are frequently associated with altered mechanical and electric function in the heart, a syndrome termed lipotoxic cardiomyopathy. [1] [2] [3] After adjusting for other cardiovascular risk factors, both diabetes and obesity confer an increased risk of sudden cardiac death, 4 -8 and are associated with altered cardiomyocyte electric properties, manifested by prolongation of the QRS and QT intervals. 9 -11 The molecular mechanisms responsible for alterations in the electric properties of cardiomyocytes and the increased incidence of sudden cardiac death have not been well elucidated. An essential question is whether the diabetes mellitus-induced cardiomyo-cyte lipid accumulation or the diabetes mellitus-induced global metabolic defects cause the increased incidence of sudden death.
Clinical Perspective on p 2821
In contrast to diabetic patients, several models of cardiac lipid accumulation have not shown increased mortality. Transgenic (TG) mice with cardiac-restricted overexpression of the peroxisome proliferation-activated receptor ␣ (PPAR␣) exhibit a cardiac metabolic phenotype that is similar to that of the diabetic heart: increased fatty acid utilization and decreased uptake and oxidation of glucose. 12 These mice, which develop cardiomyocyte lipid accumulation, demonstrate reduced potassium (K ϩ ) channel repolarizing currents. In contrast to diabetic patients, however, TG-PPAR␣ mice do not have significant prolongation of the cardiac action potential duration (APD) and do not have increased incidence of sudden death. 13 Mice with cardiac-restricted overexpression of the fatty-acid transport protein 1 (FATP1), which develop cardiomyocyte lipid accumulation, demonstrate prolongation of the QT c interval because of a reduction in repolarizing voltage-gated K ϩ currents. 14 These mice only have increased mortality when pregnant.
Peroxisome proliferator-activated receptor ␥ (PPAR␥), a transcription factor that causes lipid accumulation, insulin sensitivity, and reduced inflammation in the vessel wall, 15, 16 is typically expressed at relatively low levels in the heart. PPAR␥ suppresses cardiac growth and embryonic gene expression. 17 PPAR␥ is expressed at higher levels in the human heart, especially in humans with metabolic syndrome, than in the murine heart. 18, 19 PPAR␥ is activated by rosiglitazone and pioglitozone, drugs that are associated with heart failure and, in the case of rosiglitazone, greater cardiac mortality. 20 Mice with cardiac-specific overexpression of PPAR␥ have abnormal accumulation of intracellular lipids in cardiomyocytes, gradually develop dilated cardiomyopathy, and die suddenly in young adulthood, often before a reduction in systolic function; this premature demise is exacerbated by treatment with rosiglitazone. 18 We found that these mice have spontaneous ventricular tachyarrhythmias causing sudden death, secondary to electric remodeling. Although short-term exposure to pioglitazone, a more commonly used PPAR␥ agonist, had no effect on mortality and spontaneous ventricular arrhythmias in wild-type (WT) mice, pioglitazone further exacerbated the arrhythmic phenotype and increased the mortality in the TG-PPAR␥ mice. Our findings support an important link among cardiac PPAR␥ activation, cardiomyocyte lipid accumulation, and cardiac electrophysiological remodeling and describe a model for the greater incidence of sudden death in patients with diabetes mellitus.
Methods
A detailed description of methods and reagents used is provided in the online-only Data Supplement.
Telemetry, ECG Analysis, and Monophasic Action Potential Recordings
Telemetry devices (Data Sciences International, model EA-F20) were implanted in 10-week-old mice. Recordings were begun 1 week after implantation. Intervals were measured manually using Ponemah 3 software. For in vivo monophasic action potential (MAP) recordings, under general anesthesia, a thoracotomy was made between the ribs of the left side of the thorax, and a 0.25-mm-tip electrode was pressed lightly against the anterior surface of the left ventricle (LV). The ground electrode was pressed against the inner surface of the rib cage. Signals were amplified and filtered as described. 21
Echocardiography
Transthoracic echocardiography was performed on isoflurane-anesthetized mice using a high-resolution imaging system with a 30-MHz imaging transducer (Vevo 770; VisualSonics). 18
Isolation of Cardiomyocytes and Cellular Electrophysiology
Cardiomyocytes were isolated using methods previously described. 22 Membrane currents, from noncontracting rod-shaped cells with clear striations, were measured by the whole-cell patch-clamp method 23 using a MultiClamp 700B amplifier (Axon Instruments, Union City, CA). Solutions and voltage clamp methodologies are further described in the online-only Data Supplement.
Optical Mapping
High-resolution optimal mapping experiments were performed on 16-week old TG-PPAR␥ and WT littermate control mice as previously described. 24 -26 Briefly, hearts were isolated and perfused by the Langendorff method with warm (37°C) oxygenated Tyrode solution. After stabilization, the heart was stained with the voltagesensitive dye Di-4-ANEPPs (8 L of 2-mmol/L stock solution dissolved in DMSO), and contraction was inhibited with blebbistatin (5 mol/L). The heart was stimulated with a platinum electrode at 100-ms intervals.
Real-Time Polymerase Chain Reaction
Samples of ventricular tissue from 10 to 12 week old PPAR␥ and WT littermate mice were used for real-time polymerase chain reaction. Real-time polymerase chain reaction was performed using an Applied Biosystems StepOne Plus real-time polymerase chain reaction system and inventoried primers (Applied Biosystems). Polymerase chain reactions were performed, in duplicate, for 40 cycles with automated detection of crossing threshold.
Immunoblots
The preparation and immunoblotting of heart homogenates was performed as described. 27 Chemiluminescence signal was obtained using a Kodak Image Station and signal intensities quantified using ImageJ software.
Immunohistochemistry
Heart tissue was fixed with 4% paraformaldehyde, embedded in paraffin wax, and then sectioned. Sections were incubated with anti-Cx43 (1:200) or nonimmune rabbit polyclonal immunoglobulin G at 4°C overnight. For DAB staining, sections were exposed sequentially to 0.3% H 2 O 2 , antirabbit swine antibody conjugated to biotin (1:500, DakoCytomation) for 1 hour, peroxidase-labeled ABC (VECTASTAIN ABC Kit, Vector Laboratories), and finally developed with DAB solution (ImmPACT DAB Peroxidase Substrate, Vector Laboratories). Sections were counterstained with hematoxylin. For immunofluorescent staining, after reaction with antirabbit donkey antibody conjugated to Alexa Fluor 488 (1:500, Invitrogen), sections were counterstained with DAPI.
Statistical Analysis
Results are presented as meanϮSEM. The nonparametric Mann-Whitney U test was used for comparisons with n Ͻ10, and the unpaired t test with equal variances was used for comparisons of larger groups. A 2-tailed value of PϽ0.05 was considered statistically significant, except for ECG intervals and premature ventricular complexes (PVCs) burden where the Bonferroni correction was used for multiple comparisons. Linear regression analysis was performed using GraphPad Software.
Results
Two lines of TG-PPAR␥1 mice have been developed and reported, 18 showing similar phenotypes, albeit with different severities. The high-expressing line (alpha-myosin heavychain promoter [MHC] PPAR␥1H) demonstrated a reduced ejection fraction by 4 months of age. The MHC-PPAR␥1H mice had significantly reduced lifespan, with 50% mortality at 3 months of age before the clinical development of heart failure. 18 The MHC-PPAR␥1H mouse line was used for all experiments.
Young Adult PPAR␥ Mice Have Normal Echocardiograms and Histology
We performed echocardiography of 10 to 12 week old TG-PPAR␥ and WT littermate mice. Left ventricular systolic dimension and fractional shortening were within normal limits 28 for PPAR␥ mice at this age ( Figure 1A -C). Histological examination did not demonstrate increased fibrosis ( Figure 1D ). These results suggest that the increased mortality is not related to systolic dysfunction or fibrosis. Gross structural analysis revealed that the thickness and fiber direction across the ventricular walls did not change significantly in the 10-to 12-week-old PPAR␥ mice compared with WT littermate controls ( Figure 1D ). The PPAR␥ mice have mild cardiac hypertrophy because the heart weight:body weight ratio is modestly increased, 13% above WT (onlineonly Data Supplement Figure I ), consistent with prior reports from PPAR␥ agonist-treated mice. 17
PPAR␥ Mice Have Fatal Ventricular Arrhythmias
We hypothesized that an arrhythmia was the most likely cause of the sudden death and implanted telemeters to monitor the heart rhythm of 10-week-old TG-PPAR␥ and WT littermate mice. Echocardiograms, performed before telemeter implantation, demonstrated normal LV size and function. The average daily heart rate of the TG-PPAR␥ mice was similar to WT mice at 12 and 16 weeks of age ( Figure  2A ). The QRS duration was significantly prolonged for 16-week-old TG-PPAR␥ mice compared with age-matched WT littermates ( Figure 2B and 2C). The QT interval was significantly prolonged at 12 and 16 weeks in TG-PPAR␥ mice compared with WT ( Figure 2B and 2D) .
The TG-PPAR␥ mice had significantly increased ventricular arrhythmias compared with WT at 12 and 16 weeks of age. Premature ventricular complexes were frequent in the PPAR␥ mice, averaging 7.4 PVCs/h in 12-week-old mice compared with Ͻ0.2 PVCs/h (Ϸ5 PVCs/d) in age-matched WT mice ( Figure 2E ). Complex ectopy, such as paired PVCs or nonsustained ventricular tachycardia, occurred frequently in TG-PPAR␥ mice (0.08/h at 12 weeks, 1.2/h at 16 weeks) and was never observed in WT littermates. Sustained ventricular tachycardia was the cause of death in 2 of 3 TG-PPAR␥ mice undergoing long-term monitoring; the third mouse died from bradycardia. Death due to bradycardia is common in TG mouse models of heart disease whereas death from spontaneous ventricular tachycardia is unusual. 29, 30 
Prolonged APD and Decreased K ؉ Current Density in PPAR␥ Mice
The prolongation of the QT interval may be due to abnormalities in cardiomyocyte depolarization and/or repolarization. Monophasic action potentials, which are extracellular waveforms, were used to quantify ventricular repolarization. We measured the MAPs in WT and TG-PPAR␥ mice through a small thoracotomy by placing an electrode on the anterolateral surface of the beating heart during normal sinus rhythm. The APD measurements in WT mice are similar to the in vitro findings previously reported for murine heart. 21 We found that the APD 20 (PPAR␥: 5.2Ϯ0.7 ms; WT 2.4Ϯ0.3 ms; PϽ0.01) and APD 50 (PPAR␥: 10.7Ϯ1.0 ms; WT 5.9Ϯ0.4 ms; PϽ0.01) were significantly prolonged in 12week-old TG-PPAR␥ mice compared with age-matched littermates ( Figure 3A and 3B). The APD 90 was not significantly different in TG-PPAR␥ and WT mice, Pϭ0.44. In the TG-PPAR␥ mice, the longer phase 2 of the action potential likely causes increased activation of K ϩ currents in phase 3 of the action potential, enabling a compensatory faster phase 3 repolarization. The prolongation of early repolarization (APD 20 and APD 50 ), without significant prolongation of the APD 90 , can be arrhythmogenic. 31 The action potential waveforms, measured using the perforated patch clamp technique at 35°C and stimulating at 1000-ms intervals, were prolonged in the ventricular myocytes from 10-to 12-week-old TG-PPAR␥ mice compared with age-matched WT littermate controls ( Figure 3C ). Consistent with the in vivo MAP recordings, the APD 20 and APD 50 in the TG-PPAR␥ cardiomyocytes were significantly increased compared with control cardiomyocytes (PϽ0.001; Figure 3D ). The APD 90 in the TG-PPAR␥ cardiomyocytes was also significantly increased compared with control cardiomyocytes (PϽ0.001; Figure 3B ). The difference in rate between the MAP recordings and patch-clamp recording may explain the difference in APD 90 estimates because rate can modify repolarization currents and calcium handling.
The repolarization phase of the cardiac action potential is dependent on a balance between inward depolarizing Ca 2ϩ and Na ϩ currents and outward repolarizing K ϩ currents. Whole-cell currents were recorded at room temperature from 10-to 12-week-old TG-PPAR␥ mice and corresponding age-matched littermate controls. Voltage-dependent Na ϩ and Ca 2ϩ current densities and current voltage (I-V) relationship were similar in the TG-PPAR␥ and WT mice ( Figure 4A and 4B). Boltzmann fits of the activation and inactivation revealed no changes in Na ϩ and Ca 2ϩ channels' V 50 for activation and for inactivation. A late persistent Na ϩ current was not observed in the TG-PPAR␥ mice ( Figure 4A , insets). The voltage-dependent K ϩ currents, in contrast, were significantly altered in the PPAR␥ mice compared with the WT mice ( Figure 4C ). In mice, at least 4 distinct voltagedependent K ϩ currents have been identified. 32, 33 Peak outward K ϩ current (I K,peak ) was reduced in the PPAR␥ mice (44.2Ϯ4.2 picoamps/picofarads [pA/pF]) compared with WT mice (60.4Ϯ5 pA/pF; Pϭ0.02). The decay phases of the voltage-dependent K ϩ currents in adult mouse cardiomyocytes may be fit 13 by the sum of 2 exponentials, which denotes the fast transient K ϩ current I to,f , a rapidly activating, very slowly inactivating current, I K,slow , and a noninactivating current, I ss . 32, 33 Analysis of the decay phases demonstrated a statistically significant reduction in the current density of I K, slow (WT: 23.8Ϯ2.1 pA/pF; PPAR␥ : 14.1Ϯ1.3 pA/pF; PϽ0.001), and a nonstatistically significant reduction in current densities of I to,f (WT: 22.4Ϯ2.8 pA/pF; PPAR␥: 16.2Ϯ3 pA/pF; Pϭ0.15; Figure 4C ). There was no significant change in the current density of I ss (WT: 10.8Ϯ0.8 pA/pF; PPAR␥: 11.8Ϯ0.8 pA/pF; Pϭ0.34; Figure 4C and 4D) or the current density of the inward rectifying current, I K1 (not shown), in the TG-PPAR␥ mice compared to WT mice. Cardiomyocytes had the same average size as shown by whole-cell membrane capacitance; the resting membrane potential and action potential amplitude (APA) were not significantly different in the PPAR␥ and WT littermate controls (online-only Data Supplement Table I ).
The reduction in the I K,slow current density in the TG-PPAR␥ mice was confirmed using a pharmacological approach. After exposure to 50 mol/L 4-AP, WT cardiomyocytes showed a marked reduction in I K,slow ( Figure 5A ). The 4-AP-sensitive I K,slow current, however, was markedly reduced in cardiomyocytes from PPAR␥ mice ( Figure 5A and 5B ). Linear regression of the 4-AP-sensitive current demonstrated a significant difference in the slopes (pA ⅐ pF Ϫ1 ⅐ mV Ϫ1 ) for the WT and PPAR␥ mice (WT: 0.211Ϯ0.002; PPAR␥: 0.126Ϯ0.002; Pϭ0.002; nϭ21 and 26, respectively). These data suggest that the prolongation of APD in PPAR␥ mice was primarily due to a reduction in I K,slow current. We also measured the effect of 4-AP inhibition on APD concurrently by switching from voltage-clamp to current-clamp mode. Intracellular calcium was buffered to 10 nmol/L at a temperature of 22°C to optimize cardiomyocyte condition. Under these conditions, the APD in PPAR␥ was still prolonged. Blocking 4-AP-sensitive current in WT cardiomyocytes prolonged the APD to a larger extent than in PPAR␥ cardiomyocytes. After exposure to 4-AP, the APD was not significantly different in WT and PPAR␥ mice ( Figure 5C ). Properties of Na ϩ , Ca 2ϩ and K ϩ currents. A, I-V relationship for Na ϩ current in WT and PPAR␥ mice. Insets: WT and PPAR␥ current traces. B, I-V relationship for Ca 2ϩ current. C, Voltage-dependent K ϩ current tracings for WT and PPAR␥ mice. Cardiomyocytes were held at a holding potential of Ϫ80 mV. A brief (15 ms) voltage step to Ϫ40 mV was used to activate and inactivate Na ϩ channels. After a brief return to Ϫ80 mV, voltage-dependent K ϩ currents were elicited with voltage steps between Ϫ60 mV and ϩ50 mV in 10-mV increments for 4 seconds with 10 seconds interval. D, Graph of current density of I K, peak , I to,f , I K,slow , and I ss currents. The decay phases of the outward K ϩ currents evoked during 4.0 seconds depolarizing voltage step to ϩ40 mV were fit by a double exponential function. MeanϮSEM. WT: nϭ43; PPAR␥: nϭ31. *PϽ0.05; ***PϽ0.001. pA/pF indicates picoamps/picofarads; WT, wild type; and PPAR␥, peroxisome proliferator-activated receptor ␥. Figure 4 . We obtained 4-AP-sensitive current by off-line digital subtraction of records before and after 4-AP application. B, Graph of current density of 4-AP-sensitive current for WT and TG-PPAR␥ mice. WT: nϭ26; PPAR␥: nϭ21. MeanϮSEM. C, Graph of APD before and after (gray) 4-AP exposure. Before 4-AP exposure, differences at half-width, 20%, 50% and 90% repolarization between WT and PPAR␥ are statistically significant (**PϽ0.01, ***PϽ0.001). After 4-AP (gray bars), differences between WT and PPAR␥ are not statistically significant. WT: nϭ34; PPAR␥: nϭ22. Meanϩ SEM.
Reduced Expression of Voltage-Dependent K ؉ Channels in PPAR␥ Hearts
Gene expression was determined by real-time quantitative polymerease chain reaction of RNA extracted from the ventricular tissue of 10-to 12-week-old mice. The messenger RNA (mRNA) expression of K V 2.1, which contributes to I K,slow , 34, 35 was significantly reduced in the TG-PPAR␥ mice compared with WT littermates. The mRNA expression of K V 4.2, which encodes I to,f 36 was not significantly reduced. In contrast to larger animals, K V 4.3 is not required for functional I to,f in the mouse. 37 Protein expression of the voltagedependent K ϩ channels was measured using ventricular homogenates. In contrast to the modest or absent changes in mRNA expression, the protein expression of these channels was markedly reduced in the TG-PPAR␥ mice ( Figure 6B and 6C). The protein levels of K V 1.5 and K V 2.1, which form I K,slow in mouse, was significantly reduced to 67% and 50%, respectively, of WT littermate controls. These reductions in protein expression are consistent with the findings of reduced I K,slow current density ( Figure 5 ). The protein expression of K V 4.2, which forms I to,f , was also markedly reduced in the PPAR␥ mice, to 27% of the control level. Although the current density of I to,f was reduced in the PPAR␥ mice, the reduction in protein expression of this subunit is far greater, suggesting upregulation of activity of the remaining K V 4.2. The K v 1.4 channel, which also contributes to I to , is also reduced significantly.
Prolongation of APD Does Not Cause Triggered Activity
To better understand the mechanisms of ectopy and arrhythmia, ventricular myocytes were paced through the patch pipette in perforated configuration by current pulses (amplitude 0.1-0.4 nA, 3 ms duration) at intervals from 1000 to 250 ms. Under these conditions, we did not observe any early after-depolarizations (EADs) or delayed after-depolarizations (DADs) in PPAR␥ or WT cardiomyocytes (nϭ32, from 3 mice in each group).
Connexin43 Is Reduced but Conduction Velocity Is Normal
Connexin43 (Cx43, the major ventricular gap junction protein) mRNA and protein expression was significantly down-regulated in the PPAR␥ mice, to 31% ( Figure 7A ) and 14% ( Figure 7B and 7C) , respectively, of WT littermates. Other intercalated disk proteins, such as cadherin and plakoglobin, were also reduced ( Figure 7C ). Cx43 was decreased throughout the heart, as determined by immunohistochemistry of sections isolated from the anterior, lateral, and posterior walls of the LV and the right ventricle ( Figure 7D ). The reduction in Cx43 occurred before systolic dysfunction developed. To assess the effect of Cx43 reduction on ventricular impulse propagation, we optically mapped cardiac activation patterns in the PPAR␥ and WT littermate mice. Surprisingly, the minimum conduction velocity was not significantly reduced in the PPAR␥ mice compared with the control littermate mice (Pϭ0.55 for LV; Figure 7F ). Thus, it is not likely that the reduction in expression of Cx43 accounts for the increased propensity to develop ventricular arrhythmias and sudden death.
PPAR␥ Agonist Pioglitazone Increases Ventricular Arrhythmias in TG-PPAR␥ Mice
Transgenic PPAR␥ and WT littermates, 10 to 12 weeks of age, were fed standard mouse chow or pioglitazone-impregnated standard mouse chow for 3 weeks. Pioglitazone increased the mortality in the PPAR␥ mice (pioglitazone chow: 75% versus control chow: 25%, nϭ8 in each group) during the 3-week period but had no effect on mortality in the WT littermate animals ( Figure 8A) . To determine the mechanism(s) responsible for the pioglitazone-induced increased mortality in the TG-PPAR␥ mice, ECG telemeters were implanted into four 10-week-old TG-PPAR␥ mice and 4 WT littermate mice. Baseline telemetric measurements were initiated 4 days after implantation. Mice were then fed pioglitazone for 7 days. For TG-PPAR␥ mice, within 4 days of starting pioglitazone there was a significant increase in PVCs/h; by day 6 of pioglitazone chow, the number of PVCs/h was 15 times the baseline rate (Pϭ0.0285 by U test). Complex ventricular ectopy also increased Ϸ15-fold over the same time period ( Figure 8B and 8C) . Linear regression modeling of the time course shows a slope that is significantly different from zero (F test ϭ0.017). Complex ventricular arrhythmias were never observed in the WT littermate mice in the absence or presence of pioglitazone ingestion, and even after 3 weeks of pioglitazone chow, the WT mice did not have an increase in PVCs/h. During the relatively short (and intermittent) monitoring period, sudden cardiac death was captured in 1 TG-PPAR␥ animal caused by spontaneous polymorphic ventricular tachycardia degenerating to ventricular fibrillation. We examined the ion channel protein expression from the hearts of TG-PPAR␥ mice fed either control or pioglitazone chow for 1 week. K V 1.5, which encodes I Kslow , was decreased by 35% ( Figure 8C ) in the pioglitazone-fed TG-PPAR␥ mice compared with control chow-fed TG-PPAR␥ mice (Pϭ0.11 by U test). These results suggest that PPAR␥ agonist-induced activation of PPAR␥, when overexpressed in the heart, has a deleterious effect on mortality and arrhythmogenesis.
Discussion
Despite the increasing prevalence of obesity and diabetes mellitus, little is known about the contribution of metabolic abnormalities to the pathophysiology of arrhythmias and sudden cardiac death. Increased cardiomyocyte lipid stores are observed in obese and diabetic patients, and this may contribute to arrhythmias. In diabetic patients, plasma free fatty acid concentration correlates with the frequency of ventricular premature complexes, and patients with ischemic cardiomyopathy and obesity have more ventricular tachycardia than nonobese patients with ischemic cardiomyopathy. 38, 39 Diabetes mellitus and obesity are also associated with an increased risk of cardiomyopathy, independent of the presence of hypertension or coronary artery disease, which may represent a direct toxic effect of increased intracellular lipids. 2, 40 We used a gain-of-function approach to show that cardiomyocyte-specific metabolic derangements associated with the cardiac-specific overexpression of PPAR␥ leads to ventricular arrhythmias and sudden cardiac death. The overexpression of PPAR␥, which can regulate transcription of numerous targets, and/or the subsequent cardiomyocyte lipid accumulation led to reductions in the expression and current density of key repolarizing currents, prolongation of the APD in vitro and in vivo, and the reduced expression of intercalated disc proteins. The electric remodeling of the heart ultimately caused a markedly increased incidence of malignant ventricular arrhythmias and sudden cardiac death, which occurred before the onset of systolic dysfunction but after the development of cardiomyocyte lipid accumulation. Treating the TG-PPAR␥ mice but not WT littermate controls with a PPAR␥ agonist increased the incidence of arrhythmias and mortality.
Although PPAR␥ expression is normally relatively low in the heart, its expression is increased in several forms of heart disease including cardiomyopathy 41 and cardiac hypertrophy 42, 43 and in the diabetic heart. 44 Despite its low expression in the heart, tissue-specific loss of PPAR␥ leads to cardiac hypertrophy with preserved systolic function. 17 Peroxisome proliferation-activated receptor ␥ suppresses cardiac growth and embryonic gene expression and inhibits nuclear factor B activity in vivo 17 and may also suppress inflammation. 45 The cardiac metabolic abnormalities found in the TG-PPAR␥ mice, specifically the lipid accumulation within cardiomyocytes, 18 mimic many of the abnormalities found in the hearts of diabetic and obese/metabolic syndrome patients. 19 The tissue-restricted TG overexpression of PPAR␥ enables the preferential shunting of plasma triglycerides and fatty acids to the heart. Pioglitazone treatment in TG-PPAR␥ mice would further enhance cardiac PPAR␥ activity. The systemic effects of pioglitazone in WT mice, in contrast, by channeling a greater proportion of plasma triglycerides and fatty acids to adipose tissues, may actually reduce lipid uptake by the heart relative to the periphery. 46 The differential activation of cardiac versus peripheral PPAR␥ and the shunting and accumulation of lipid in either the heart or the periphery likely account for the TG phenotype and effects of pioglitazone. In WT animals, pioglitazone had no effect on mortality or incidence of ventricular tachyarrhythmias because pioglitazone activation of adipose-tissue PPAR␥ predominates. In the TG-PPAR␥ mice, although pioglitazone likely activated both cardiac and adipose PPAR␥, the level of expression of the cardiac PPAR␥ likely favored additional cardiomyocyte lipid accumulation and increased electric remodeling, as reflected by an increased incidence of ventricular tachyarrhythmias, reduced expression of K ϩ channels, and increased mortality. In humans, the underlying ratio of adipose to cardiac PPAR␥ expression and the differential effects of different PPAR␥ agonists (eg, pioglitazone versus rosiglitazone) likely modulates the beneficial versus toxic effects of these drugs on the heart.
The molecular mechanisms responsible for the reduction in K ϩ channel expression in the TG-PPAR␥ mice are not known. The PPAR␥ overexpression and lipid loading may exert their effects via transcriptional, translational, and/or post-translational processes. Cardiac-specific overexpression of PPAR␣, a key regulator of diabetes mellitus-induced lipid metabolic dysregulation, also induced ion channel remodeling, predominantly a reduction of I to,f and a compensatory increase in I ss . 13 No change in I K,slow current was found in young TG-PPAR␣ mice. In MHC-FATP TG mice, however, the I peak and I K,slow currents were selectively attenuated, without change in I to,f and I ss . 14 In our study of the cardiacspecific overexpression of MHC-PPAR␥ mice, I peak and I K,slow were significantly reduced, with a trend toward reduction in I to,f current. The remodeling of K ϩ channels in the TG-PPAR␥ mice is similar to the remodeling found in the MHC-FATP mice. In the TG-PPAR␣ and TG-FATP mice, the electrophysiological phenotypes were less severe than the TG-PPAR␥ mice, and sudden cardiac death (in nonpregnant animals) was not reported. 13, 14 Different transcriptional and/or posttranscriptional pathways may be modified in these mice, which causes changes in distinct K ϩ currents. In all 3 animal models, fatty-acid accumulation and utilization are increased. Glucose uptake and metabolism are decreased in the MHC-FATP and MHC-PPAR␣ mice whereas in the MHC-PPAR␥ mice glucose uptake is increased.
Cardiac-specific loss of Cx43 is associated with significant conduction slowing and a higher propensity for the development of ventricular arrhythmias and sudden death. 24, 26 Large reductions of Cx43 expression levels are required to significantly affect epicardial conduction velocities. A 50% reduction of Cx43 protein does not produce significant conduction slowing, but a 70% to 95% reduction of Cx43 protein results in reduced conduction velocity, increased dispersion of conduction, and enhanced arrhythmogenicity. [47] [48] [49] The Ϸ12week-old TG-PPAR␥ mice demonstrate Ϸ70% reduction in Cx43 mRNA and Ϸ85% reduction in Cx43 protein amounts. The lack of significant slowing of the conduction velocity in the TG-PPAR␥ mice suggests that other proteins or posttranslational modifications must be compensating for the marked reduction in Cx43 protein levels. Furthermore, the finding of normal conduction velocity implies that the reduction in Cx43 protein in the TG-PPAR␥ mice does not contribute significantly to the increased incidence of ventricular arrhythmias and mortality. The wide QRS may be due to damage to the His-Purkinje system rather than reduced Cx43 levels. The reduced levels of other intercalated disk proteins is probably not a direct effect of PPAR␥ because in some cancer models, PPAR␥ overexpression increases cadherins. 50 The reduction in intercalated disk proteins may contribute to the reduction in Cx43 protein.
In summary, we have found that overexpression of PPAR␥ in the heart is sufficient to induce action potential remodeling and to cause an acquired long-QT syndrome phenotype. The reduced repolarization reserve increases the incidence of spontaneous ventricular arrhythmias and sudden death. Pioglitazone treatment increases the incidence of complex ventricular arrhythmias and sudden death in the TG-PPAR␥ mouse but not in WT littermates. Although an important limitation of this work is that the ion channels responsible for cardiac-action-potential repolarization in mice are different than in humans, the TG-PPAR␥ mouse recapitulates an arrhythmic phenotype observed in patients with diabetes mellitus and metabolic syndrome. 
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